FDA COVID-19: new real-world evidence data collection

• FDA search for evidence based insights from health records for COVID-19
• Aetion applies big-data analytics to patients’ electronic health records to evaluate safety and effectiveness for pharmaceutical and biotech companies
• Real-world data collection from multiple sources
• The rapid analytics are expected to help FDA better evaluate proposed diagnostics, vaccines, and treatments as the pandemic continues to spread, and cases, hospitalisations, and deaths increase throughout the country.

Click here to learn more

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

ref: JUN2020VN001